bpc-157 benefits scientific evidence review Frontiers The Hidden Risks of BPC‑157:
Description
Does NOT release IGF-1: Eliminating the risk of acromegaly or proliferative tissue growth
Besides affecting B12 absorption, evidence exists that CUBN polymorphisms may cause reduced transport of B12 in the small intestine as well
Research or further manufacturing use only, not for food or drug use
Lipotropic injections contain a combination of ingredients designed to promote weight loss, remove toxins, and provide energy
